Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C. [electronic resource]
Producer: 20180409Description: 164 p. digitalISSN:- 1743-422X
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents -- therapeutic use
- Base Sequence
- Carbamates
- Drug Combinations
- Drug Resistance, Viral -- drug effects
- Female
- Genotype
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- therapeutic use
- Interferons -- therapeutic use
- Isoquinolines -- therapeutic use
- Liver Cirrhosis -- virology
- Male
- Middle Aged
- Prevalence
- Pyrrolidines
- RNA, Viral -- isolation & purification
- Republic of Korea
- Sulfonamides -- therapeutic use
- Sustained Virologic Response
- Treatment Failure
- Valine -- analogs & derivatives
- Viral Nonstructural Proteins -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.